Show simple item record

dc.contributor.authorEspart Herrero, Anna
dc.contributor.authorArtime, Sebastián
dc.contributor.authorTort Nasarre, Glòria
dc.contributor.authorYara Varón, Edinson
dc.date.accessioned2020-06-23T07:28:03Z
dc.date.available2020-06-23T07:28:03Z
dc.date.issued2018
dc.identifier.issn1756-5901
dc.identifier.issn1756-591X
dc.identifier.urihttp://hdl.handle.net/10459.1/69107
dc.description.abstractCadmium (Cd) is a non-physiological heavy metal that can be harmful at low concentrations. Increasing anthropogenic activities are incrementing the risk of accumulation of this heavy metal in different organs and tissues of the body. In the case of pregnant women, the threat is more serious due to the implications affecting not only their own health but also fetal development as well. Metallothioneins (MTs), small cysteine-rich proteins, are involved in zinc (Zn) and copper homeostasis in mammals but can, however, also bind with Cd if present. The accumulation of Cd in maternal tissues (e.g. placenta, maternal blood, and mammary glands) induces the synthesis of MTs, preferably MT2, in an attempt to sequester the metal to avoid toxicity. The formed Cd–MT complexes will avoid the Cd transport from the placenta to the fetus and end up accumulating in the maternal kidneys. At the same time, high concentrations of MTs will increase the formation of Zn–MT complexes, therefore decreasing the amount of Zn ions available to be transported to the fetus by means of Zn transporters such as ZnT2, ZIP14 and DMT1. Although MTs cannot transport Cd from the mother to the fetus, the divalent DMT1 transporter is suggested to carry the metal to the fetus. As a consequence, the low levels of Zn(II) in the fetus, together with the presence of Cd(II) coming from the mother either via the placenta and cord blood or via breast milk induce changes in the fetal development including fetal growth retardation, and low weight or height of the newborn. Likewise, the concentrations of Cd(II) in the newborn can cause alterations such as cognitive disabilities. In summary, the presence of Cd(II) in the maternal tissues will induce MT synthesis in an attempt to detoxify these tissues and reduce the possible toxicity of Cd in fetal and newborn tissuesca_ES
dc.language.isoengca_ES
dc.publisherRoyal Society of Chemistryca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1039/c8mt00174jca_ES
dc.relation.ispartofMetallomics, 2018, vol. 10, núm. 10, p. 1359-1367ca_ES
dc.rightscc-by (c) Royal Society of Chemistry, 2018ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.otherCadmica_ES
dc.subject.otherAlletamentca_ES
dc.subject.otherEmbaràsca_ES
dc.titleCadmium exposure during pregnancy and lactation: materno-fetal and newborn repercussions of Cd(II), and Cd–metallothionein complexesca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.identifier.idgrec027413
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.1039/c8mt00174j


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Royal Society of Chemistry, 2018
Except where otherwise noted, this item's license is described as cc-by (c) Royal Society of Chemistry, 2018